Glaxo Wins Injunction in Battle Over Asthma Drug

GlaxoSmithKline scored a minor victory in the battle to keep sales of its $9 billion-a-year asthma treatment Advair from being lost to generic competitors.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news